These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 27854388)

  • 1. Prediction of stillbirth from placental growth factor at 11-13 weeks.
    Akolekar R; Machuca M; Mendes M; Paschos V; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Nov; 48(5):618-623. PubMed ID: 27854388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of stillbirth from placental growth factor at 19-24 weeks.
    Aupont JE; Akolekar R; Illian A; Neonakis S; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Nov; 48(5):631-635. PubMed ID: 27854395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of stillbirth from biochemical and biophysical markers at 11-13 weeks.
    Mastrodima S; Akolekar R; Yerlikaya G; Tzelepis T; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Nov; 48(5):613-617. PubMed ID: 27561595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of stillbirth from maternal factors, fetal biometry and uterine artery Doppler at 19-24 weeks.
    Akolekar R; Tokunaka M; Ortega N; Syngelaki A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Nov; 48(5):624-630. PubMed ID: 27854387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of model for prediction of placental dysfunction-related stillbirth from maternal factors, fetal weight and uterine artery Doppler at mid-gestation.
    Ashoor G; Syngelaki A; Papastefanou I; Nicolaides KH; Akolekar R
    Ultrasound Obstet Gynecol; 2022 Jan; 59(1):61-68. PubMed ID: 34643306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers of impaired placentation at 35-37 weeks' gestation in the prediction of adverse perinatal outcome.
    Ciobanou A; Jabak S; De Castro H; Frei L; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2019 Jul; 54(1):79-86. PubMed ID: 31100188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for pre-eclampsia at 11-13 weeks' gestation: use of pregnancy-associated plasma protein-A, placental growth factor or both.
    Mazer Zumaeta A; Wright A; Syngelaki A; Maritsa VA; Da Silva AB; Nicolaides KH
    Ultrasound Obstet Gynecol; 2020 Sep; 56(3):400-407. PubMed ID: 32441401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Competing-risks model in screening for pre-eclampsia in twin pregnancy according to maternal factors and biomarkers at 11-13 weeks' gestation.
    Francisco C; Wright D; Benkő Z; Syngelaki A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Nov; 50(5):589-595. PubMed ID: 28556556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of stillbirth from maternal demographic and pregnancy characteristics.
    Yerlikaya G; Akolekar R; McPherson K; Syngelaki A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Nov; 48(5):607-612. PubMed ID: 27561693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uterine artery pulsatility index at 30-34 weeks' gestation in the prediction of adverse perinatal outcome.
    Valiño N; Giunta G; Gallo DM; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Mar; 47(3):308-15. PubMed ID: 25970847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biophysical and biochemical markers at 30-34 weeks' gestation in the prediction of adverse perinatal outcome.
    Valiño N; Giunta G; Gallo DM; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Feb; 47(2):194-202. PubMed ID: 26094952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of uterine artery Doppler in interpreting low PAPP-A values in first-trimester screening for Down syndrome in pregnancies at high risk of impaired placentation.
    Herraiz I; López-Jiménez EA; García-Burguillo A; Nieto O; Villar OP; Escribano D; Galindo A
    Ultrasound Obstet Gynecol; 2009 May; 33(5):518-23. PubMed ID: 19402101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired placentation in women with chronic hypertension who develop pre-eclampsia.
    Panaitescu AM; Akolekar R; Kametas N; Syngelaki A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Oct; 50(4):496-500. PubMed ID: 28470791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of small-for-gestational-age neonates: screening by biophysical and biochemical markers at 30-34 weeks.
    Bakalis S; Peeva G; Gonzalez R; Poon LC; Nicolaides KH
    Ultrasound Obstet Gynecol; 2015 Oct; 46(4):446-51. PubMed ID: 25826154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contingent screening for preterm pre-eclampsia.
    Wright D; Gallo DM; Gil Pugliese S; Casanova C; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 May; 47(5):554-9. PubMed ID: 26643929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeat measurements of uterine artery pulsatility index, mean arterial pressure and serum placental growth factor at 12, 22 and 32 weeks in prediction of pre-eclampsia.
    Andrietti S; Carlucci S; Wright A; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Aug; 50(2):221-227. PubMed ID: 28078815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in uterine artery Doppler velocimetry and circulating angiogenic factors in the first half of pregnancies delivering a small-for-gestational-age neonate.
    Triunfo S; Crovetto F; Rodriguez-Sureda V; Scazzocchio E; Crispi F; Dominguez C; Gratacos E; Figueras F
    Ultrasound Obstet Gynecol; 2017 Mar; 49(3):357-363. PubMed ID: 27241056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal serum placental growth factor (PlGF) in small for gestational age pregnancy at 11(+0) to 13(+6) weeks of gestation.
    Poon LC; Zaragoza E; Akolekar R; Anagnostopoulos E; Nicolaides KH
    Prenat Diagn; 2008 Dec; 28(12):1110-5. PubMed ID: 19003787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biophysical and biochemical markers at 35-37 weeks' gestation in the prediction of adverse perinatal outcome.
    Valiño N; Giunta G; Gallo DM; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Feb; 47(2):203-9. PubMed ID: 26224608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Placental size and the prediction of severe early-onset intrauterine growth restriction in women with low pregnancy-associated plasma protein-A.
    Proctor LK; Toal M; Keating S; Chitayat D; Okun N; Windrim RC; Smith GC; Kingdom JC
    Ultrasound Obstet Gynecol; 2009 Sep; 34(3):274-82. PubMed ID: 19672838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.